Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2014

View Archived Issues

Visual acuity improvement seen in interim results from squalamine eye drops trial

Optimization of a GPR40 agonist for type 2 diabetes

Aurigene and Orion form BET bromodomain collaboration

Nandrolone decanoate/vitamin D3 fixed-dose combination evaluated in multiple doses

Roche and Ferring collaborate on personalized female infertility treatment

Johnson & Johnson and Dana-Farber Cancer Institute establish lung cancer collaboration

DART Therapeutics changes name

Targacept begins phase I/II study of TC-6499 in diabetic gastroparesis

GSK begins phase III study of eltrombopag in myelodysplastic syndromes

Aerie Pharmaceuticals reports phase IIb results for Roclatan

Novel neurogenesis-stimulating agents disclosed by Roche

Roche divulges novel MSP receptor agonists

Bayer patent describes potential hemophilia treatments

BioMarin Pharmaceutical discloses new fusion protein for LSD

Japanese researchers present radiation-induced injury treatments

HerpV vaccine shows significant reduction in viral burden

Coronado Biosciences reports topline results from investigator-initiated pilot study

NovaBiotics begins phase IIa study of Lynovex in cystic fibrosis

Eisai submits first MAA for anticancer agent lenvatinib in Japan

Boehringer Ingelheim's idarucizumab receives FDA breakthrough therapy designation

Basilea initiates phase IIa trial of BAL-101553

Nora Therapeutics begins phase II study of NT-100 in women with recurrent pregnancy loss

Phase II results reported on refametinib in patients with pancreatic cancer

Aurinia initiates phase IIb trial of voclosporin in lupus nephritis

Cancer stemness kinase inhibitor BBI-503 tested in patients with advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...